EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel immune-nutritional prognostic ratio predicts long-term survival in stage I–III colorectal cancer

Kuan Wang, Boxiang Zhang, Kejin Li, Ziyi Zhang, Xiangyue Zeng, Jun-Min Guan, Richard Aldridge, Elizabeth Whitmore, Yipeng Pan, Lucy Yue Lau, Zeliang Zhao, Yi Chen

Frontiers in Oncology · 18.12.2025 · 15

DOI: 10.3389/fonc.2025.1694587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 18.12.2025. Verfasst von Kuan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is a common and highly lethal malignancy worldwide. Even after curative resection, patients with stage I–III disease remain at substantial risk of recurrence and mortality. The Prognostic Immune and Nutritional Index (PINI) and lymphocyte-to-monocyte ratio (LMR) have been validated as prognostic markers in cancer, yet their individual predictive performance remains limited. We developed a novel Immune-Nutritional Prognostic Ratio (INPR) integrating PINI and LMR to provide a more comprehensive assessment of immune, nutritional, and inflammatory status. This study further evaluated its value in predicting 1-, 3-, and 5-year survival in stage I–III CRC.

Methods

We retrospectively analyzed data from 556 colorectal cancer patients at two hospitals, with one serving as the validation cohort. Receiver operating characteristic (ROC) curves were used to determine optimal cutoff values for PINI and LMR, and the area under the curve (AUC) was applied to assess predictive performance. KKaplan–Meier analysis showed that lower PINI and LMR were associated with shorter overall survival (OS). The INPR, integrating both markers, demonstrated superior accuracy. Variables linked to OS were selected using the Boruta algorithm and multivariable Cox regression, and a nomogram model was developed and validated internally and externally.

Results

The Youden index identified optimal cutoff values of 3.50 for PINI and 2.65 for LMR, with low levels independently predicting shorter OS. The INPR, integrating both, stratified patients into low-, intermediate-, and high-risk groups, with 5-year OS rates of 93.30%, 59.35%, and 28.57% in the training cohort (p<0.001). INPR outperformed either marker alone, showing higher AUC. A nomogram incorporating variables selected by the Boruta algorithm and multivariable Cox regression demonstrated stable and superior prognostic performance in both internal and external validation.

Conclusion

Our findings demonstrate that INPR is a simple, accessible, and effective prognostic tool for postoperative risk stratification in stage I–III CRC patients, providing valuable guidance for optimizing individualized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerlymphocyte-to-monocyte rationomogramoverall survivalprognosis

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
  • Cancer Research Institute, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Xinjiang Key Laboratory of Translational Biomedical Engineering, Urumqi, Xinjiang, China.
  • Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Gastrointestinal Oncology Surgery, Gastroenterology Center, People's Hospital of Bortala Mongolian Autonomous Prefecture, Bole, China.
  • Department of Medicine, University of Minnesota, Minneapolis, MN, United States.

Zitieren

APA

Wang, K., Zhang, B., Li, K., Zhang, Z., Zeng, X., Guan, J. M., Aldridge, R., Whitmore, E., Pan, Y., Lau, L. Y., Zhao, Z., & Chen, Y. (2025). Novel immune-nutritional prognostic ratio predicts long-term survival in stage I–III colorectal cancer. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1694587

Vancouver

Wang K, Zhang B, Li K, Zhang Z, Zeng X, Guan JM, et al. Novel immune-nutritional prognostic ratio predicts long-term survival in stage I–III colorectal cancer. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1694587

BibTeX
@article{Wang2025,
  author = {Wang, Kuan and Zhang, Boxiang and Li, Kejin and Zhang, Ziyi and Zeng, Xiangyue and Guan, Jun-Min and Aldridge, Richard and Whitmore, Elizabeth and Pan, Yipeng and Lau, Lucy Yue and Zhao, Zeliang and Chen, Yi},
  title = {Novel immune-nutritional prognostic ratio predicts long-term survival in stage I–III colorectal cancer},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1694587}
}
Kostenlos starten →